Overall verdict
Neutral
5.1/10
1-year performance
+4.12%
Score breakdown
Up 4.1% over 1 year, 59% of the 52-week range.
Strongest: Financial strength 7.9/10. Weakest: Profitability 0.0/10.
19 analysts, target +0.1% vs the price.
Molina Healthcare, Inc. provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces in the United States. It operates through Medicaid, Medicare, Marketplace, and Other segments. The company was founded in 1980 and is headquartered in Long Beach, California.
Sector
Health Care
Industry
Health Care Providers and Services
Primary listing
Nyse
United States
CEO
Joseph Zubretsky
Founded
1999
Employees
19 000
Revenue / employee
2.4M USD
Next earnings
October 21, 2026
Institutional holders
- BlackRock, Inc.12.93%
- AQR CAPITAL MANAGEMENT LLC7.00%
- VANGUARD PORTFOLIO MANAGEMENT LLC5.49%
- Capital World Investors5.04%
- Lingotto Investment Management LLP4.94%
- VANGUARD CAPITAL MANAGEMENT LLC4.63%
- VICTORY CAPITAL MANAGEMENT INC3.90%
- FMR LLC3.68%
- STATE STREET CORP3.45%
- Other institutions59.02%
597 13F filings as of June 30, 2026: US managers above $100M, filed up to 45 days after quarter end. No insiders, no retail. A share on loan is declared by its lender and by whoever bought it from the short seller, so the total can exceed 100%.
Research uses the underlying stock’s market history. The purchase quote is calculated separately when you review your order.
52-week high
244.89 USD
52-week low
121.06 USD
1-year performance
4.12%
Rising
Year-to-date performance
8.83%
Rising
Drawdown
-20.62%
Marked drawdown
Position in the 52-week range
59% of range
Against the world ETF
Over 17 years, from September 2009 to August 2026, the share did not do better than the world ETF once risk is accounted for. It earned more, but shaking 3.2 times harder: for the risk taken, the ETF paid better.
10,000 € placed at the end of September 2009 are worth today
| Molina Healthcare | 181 158 € |
| World ETF | 74 620 € |
| S&P 500 | 123 025 € |
| Risk-free placement | 11 288 € |
The risk
- Shaking:the share moves 3.2 times as much as the world ETF.
- Worst fall:-73 % between March 2024 and February 2026. 10,000 € placed at the top fell to 2 668 €. The world ETF, at worst: -34 %. The share has not returned to its high yet.
Molina Healthcare earned 2 times as much as the world ETF since 2009
Value of 10,000 euros placed at the end of September 2009, dividends reinvested, in euros
- Molina Healthcare: 181 158 €
- World ETF: 74 620 €
- S&P 500: 123 025 €
- Risk-free placement: 11 288 €
Share price without dividends; the world ETF and the index reinvest theirs. A dividend payer is therefore understated here.
Based on past performance. This is not a recommendation.
Range: 2.30 USD - 437.78 USD (comparables only)
The price implies growth of 12.86% per year; the company grows at -4.51%.
Gross margin 5.2%, the company loses 0.0% of its revenue, ROIC -0.1%, ROE -0.2%.
Net margin
-0.02%
Negative
Sector 1.68%|S&P 12.97%
Gross margin
5.17%
Low
Return on equity (ROE)
-0.16%
Negative
Sector 10.87%|S&P 16.52%
Return on invested capital (ROIC)
-0.09%
Negative
Free cash flow margin (FCF)
0.61%
Low
Margin stability
0.8 pts
Very steady
Revenue to net income
Growth
1.8/10Revenue down 4.8% over 1 year, 18.7% a year over 5, EPS -4.5% a year over 5.
Revenue (trailing 12 months)
44.5Md USD
Revenue growth (1y)
-4.84%
Declining
Revenue growth (3y)
42.07%
Solid
EPS growth (1y)
-75.37%
Declining
EPS CAGR (5y)
-4.51%
Declining
EPS revisions (3 months)
1.88%
Revised up
Valuation
2.9/10P/E 1944.0x, forward P/E 66.0x, EV/EBITDA 5.9x. The multiple sits in the 51th percentile of its own 5-year history.
P/E (TTM)
1944.0x
Very expensive
Sector 28.2x|S&P 23.0x
Forward P/E
66.0x
Very expensive
EV / EBITDA
5.9x
Cheap
Sector 15.4x|S&P 14.5x
PEG
—
Sector 0.23|S&P 0.86
Fair value (reverse DCF)
220.04 USD
Undervalued
P/E vs its own 5-year history
among the 49% highest valuations
In line with its history
Market cap
9.9Md USD
Financial strength
7.9/10Cash covers 126.1% of the debt, net debt/EBITDA -20.7x.
Net debt / EBITDA
-20.7x
Net cash
Gearing (net debt / equity)
-24.74%
Net cash
Cash
5.0Md USD
Cash / market cap
50.43%
Very solid
Cash / total debt
126.11%
Net cash
Interest coverage
1.0x
Stretched
Net debt
-1.0Md USD
Equity
4.2Md USD
Closed daily candles, 2 years
Last close on September 24, 2026: 193.31 USD
- MM20200.13
- MM50202.21
- MM200180.93
- RSI 1443.3
Top panel: closed candles, 20, 50 and 200-day moving averages, with volume in grey. Bottom panel: 14-day RSI with dashed 30 and 70 levels.
200-day average slope, 1 month
+3.37%
200-day average slope, 3 months
+7.33%
50-day average slope, 1 month
-4.03%
Price structure
higher-low
Bullish RSI divergence
No
20-day volatility
2.16 % per day
Volatility change
-19.42%
Forecasts by fiscal year
| Fiscal year | EPS | Normalised EPS | Revenue | EBITDA | Net income |
|---|---|---|---|---|---|
| 2026 | 2.95 (6) | 5.25 (19) | 44 455 (16) | 726 (11) | 144 (7) |
| 2027 | 8.55 (6) | 9.75 (19) | 48 040 (15) | 1 004 (11) | 455 (7) |
Amounts in millions of USD, EPS in USD per share. In brackets, the number of analysts. Consensus as of September 24, 2026.
Same sub-industry: 10 companies behind the medians.
| # | Company | Code | Country | Overall / 10 | Fundamentals / 10 | Mkt cap | P/E | Net margin | Revenue growth | ROIC | Net debt / EBITDA | FCF yield | 1-year perf. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | SAUD3 | 7.4 | 6.5 | 8.0Md USD | 14.3x | 10.6 % | 1213.1 % | 10.4 % | -0.3x | 1.6 % | 5.3 % | ||
| 2 | PGNY | 7.4 | 7.6 | 2.0Md USD | 28.1x | 6.0 % | 5.3 % | 15.5 % | -3.1x | 9.0 % | 20.2 % | ||
| 3 | UNH | 6.9 | 5.8 | 333Md USD | 23.9x | 3.1 % | 0.4 % | 8.4 % | 1.9x | 7.1 % | 7.1 % | ||
| 4 | HQY | 6.7 | 6.0 | 7.5Md USD | 32.6x | 17.4 % | 7.6 % | 7.7 % | 1.4x | 6.5 % | -5.7 % | ||
| 5 | ELV | 6.4 | 5.3 | 86.4Md USD | 17.7x | 2.5 % | 1.4 % | 6.7 % | — | 7.3 % | 22.7 % | ||
| 6 | CNC | 5.7 | 4.5 | 30.7Md USD | Not meaningful (loss) | -2.5 % | 9.9 % | -12.2 % | 1.5x | 29.2 % | 89.2 % | ||
| 7 | HUM | 5.3 | 3.8 | 45.0Md USD | 35.5x | 0.9 % | 26.2 % | 4.1 % | -1.9x | 4.3 % | 47.6 % | ||
| 8 | MOH | 5.1 | 2.9 | 9.9Md USD | 1944.0x | -0.0 % | -4.8 % | -0.1 % | -20.7x | 2.7 % | 4.1 % | ||
| 9 | CLOV | 4.8 | 3.8 | 2.4Md USD | Not meaningful (loss) | -0.7 % | 55.6 % | -5.1 % | 3.5x | 3.1 % | 38.3 % |
